調査レポート | • レポートコード：QYR2104Z0707 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、基底細胞がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所治療、ヘッジホッグ経路阻害剤療法、モース手術、その他手術、その他治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・基底細胞がん治療の市場動向 ・企業の競争状況、市場シェア ・基底細胞がん治療の種類別市場規模（局所治療、ヘッジホッグ経路阻害剤療法、モース手術、その他手術、その他治療） ・基底細胞がん治療の用途別市場規模（病院、専門クリニック、その他） ・基底細胞がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・基底細胞がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・基底細胞がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・基底細胞がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・基底細胞がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Sun Pharmaceuticals、Bausch Health Companies、Taro Pharmaceuticals、Mylan） ・結論 |
Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC.
Basal cell carcinoma that is superficial and doesn’t extend very far into the skin may be treated with creams or ointments. Surgical options are Electrodesiccation and curettage (ED&C), Topical Treatment, Freezing and Mohs Surgery. Drugs options, imiquimod (Aldara) and fluorouracil (Efudex, Fluoroplex, others) are used for several weeks to treat such low-risk basal cell carcinomas. Basal cell carcinoma that spreads to other areas of the body (metastasizes) may be treated with vismodegib (Erivedge) or sonidegib (Odomzo).
The classification of Basal Cell Carcinoma Treatment includes Topical Treatment, Hedgehog Pathway Inhibitor Therapy, Mohs Surgery, Other Surgeries and Other Treatments, and the proportion of Topical Treatment in 2018 is about 30.4%. Basal Cell Carcinoma Treatment is widely used in Hospitals, Specialty Clinics and other field. The most proportion of Basal Cell Carcinoma Treatment is Hospitals, and the sales proportion in 2018 is 53.2%. Market competition is intense. Roche, Sun Pharmaceuticals, Bausch Health Companies, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Market Analysis and Insights: Global Basal Cell Carcinoma Treatment Market
The global Basal Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Basal Cell Carcinoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Basal Cell Carcinoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Basal Cell Carcinoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Basal Cell Carcinoma Treatment market.
Global Basal Cell Carcinoma Treatment Scope and Market Size
Basal Cell Carcinoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Basal Cell Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Topical Treatment
Hedgehog Pathway Inhibitor Therapy
Mohs Surgery
Other Surgeries
Other Treatments
Segment by Application
Hospitals
Specialty Clinics
Others
The largest application is in hospital, which accounted for 53.15% in 2018.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Sun Pharmaceuticals
Bausch Health Companies
Taro Pharmaceuticals
Mylan
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Basal Cell Carcinoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Topical Treatment
1.2.3 Hedgehog Pathway Inhibitor Therapy
1.2.4 Mohs Surgery
1.2.5 Other Surgeries
1.2.6 Other Treatments
1.3 Market by Application
1.3.1 Global Basal Cell Carcinoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Basal Cell Carcinoma Treatment Market Perspective (2016-2027)
2.2 Basal Cell Carcinoma Treatment Growth Trends by Regions
2.2.1 Basal Cell Carcinoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Basal Cell Carcinoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Basal Cell Carcinoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Basal Cell Carcinoma Treatment Industry Dynamic
2.3.1 Basal Cell Carcinoma Treatment Market Trends
2.3.2 Basal Cell Carcinoma Treatment Market Drivers
2.3.3 Basal Cell Carcinoma Treatment Market Challenges
2.3.4 Basal Cell Carcinoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Basal Cell Carcinoma Treatment Players by Revenue
3.1.1 Global Top Basal Cell Carcinoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Basal Cell Carcinoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Basal Cell Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Basal Cell Carcinoma Treatment Revenue
3.4 Global Basal Cell Carcinoma Treatment Market Concentration Ratio
3.4.1 Global Basal Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Basal Cell Carcinoma Treatment Revenue in 2020
3.5 Basal Cell Carcinoma Treatment Key Players Head office and Area Served
3.6 Key Players Basal Cell Carcinoma Treatment Product Solution and Service
3.7 Date of Enter into Basal Cell Carcinoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Basal Cell Carcinoma Treatment Breakdown Data by Type
4.1 Global Basal Cell Carcinoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Basal Cell Carcinoma Treatment Forecasted Market Size by Type (2022-2027)
5 Basal Cell Carcinoma Treatment Breakdown Data by Application
5.1 Global Basal Cell Carcinoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Basal Cell Carcinoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Basal Cell Carcinoma Treatment Market Size (2016-2027)
6.2 North America Basal Cell Carcinoma Treatment Market Size by Type
6.2.1 North America Basal Cell Carcinoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Basal Cell Carcinoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Basal Cell Carcinoma Treatment Market Size by Type (2016-2027)
6.3 North America Basal Cell Carcinoma Treatment Market Size by Application
6.3.1 North America Basal Cell Carcinoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Basal Cell Carcinoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Basal Cell Carcinoma Treatment Market Size by Application (2016-2027)
6.4 North America Basal Cell Carcinoma Treatment Market Size by Country
6.4.1 North America Basal Cell Carcinoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Basal Cell Carcinoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Basal Cell Carcinoma Treatment Market Size (2016-2027)
7.2 Europe Basal Cell Carcinoma Treatment Market Size by Type
7.2.1 Europe Basal Cell Carcinoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Basal Cell Carcinoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Basal Cell Carcinoma Treatment Market Size by Type (2016-2027)
7.3 Europe Basal Cell Carcinoma Treatment Market Size by Application
7.3.1 Europe Basal Cell Carcinoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Basal Cell Carcinoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Basal Cell Carcinoma Treatment Market Size by Application (2016-2027)
7.4 Europe Basal Cell Carcinoma Treatment Market Size by Country
7.4.1 Europe Basal Cell Carcinoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Basal Cell Carcinoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Basal Cell Carcinoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Type
8.2.1 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Application
8.3.1 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Region
8.4.1 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Basal Cell Carcinoma Treatment Market Size (2016-2027)
9.2 Latin America Basal Cell Carcinoma Treatment Market Size by Type
9.2.1 Latin America Basal Cell Carcinoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Basal Cell Carcinoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Basal Cell Carcinoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Basal Cell Carcinoma Treatment Market Size by Application
9.3.1 Latin America Basal Cell Carcinoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Basal Cell Carcinoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Basal Cell Carcinoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Basal Cell Carcinoma Treatment Market Size by Country
9.4.1 Latin America Basal Cell Carcinoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Basal Cell Carcinoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Basal Cell Carcinoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Type
10.2.1 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Application
10.3.1 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Country
10.4.1 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Basal Cell Carcinoma Treatment Introduction
11.1.4 Roche Revenue in Basal Cell Carcinoma Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Sun Pharmaceuticals
11.2.1 Sun Pharmaceuticals Company Details
11.2.2 Sun Pharmaceuticals Business Overview
11.2.3 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Introduction
11.2.4 Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Treatment Business (2016-2021)
11.2.5 Sun Pharmaceuticals Recent Development
11.3 Bausch Health Companies
11.3.1 Bausch Health Companies Company Details
11.3.2 Bausch Health Companies Business Overview
11.3.3 Bausch Health Companies Basal Cell Carcinoma Treatment Introduction
11.3.4 Bausch Health Companies Revenue in Basal Cell Carcinoma Treatment Business (2016-2021)
11.3.5 Bausch Health Companies Recent Development
11.4 Taro Pharmaceuticals
11.4.1 Taro Pharmaceuticals Company Details
11.4.2 Taro Pharmaceuticals Business Overview
11.4.3 Taro Pharmaceuticals Basal Cell Carcinoma Treatment Introduction
11.4.4 Taro Pharmaceuticals Revenue in Basal Cell Carcinoma Treatment Business (2016-2021)
11.4.5 Taro Pharmaceuticals Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Basal Cell Carcinoma Treatment Introduction
11.5.4 Mylan Revenue in Basal Cell Carcinoma Treatment Business (2016-2021)
11.5.5 Mylan Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Basal Cell Carcinoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Topical Treatment
Table 3. Key Players of Hedgehog Pathway Inhibitor Therapy
Table 4. Key Players of Mohs Surgery
Table 5. Key Players of Other Surgeries
Table 6. Key Players of Other Treatments
Table 7. Global Basal Cell Carcinoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Basal Cell Carcinoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Basal Cell Carcinoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Basal Cell Carcinoma Treatment Market Share by Regions (2016-2021)
Table 11. Global Basal Cell Carcinoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Basal Cell Carcinoma Treatment Market Share by Regions (2022-2027)
Table 13. Basal Cell Carcinoma Treatment Market Trends
Table 14. Basal Cell Carcinoma Treatment Market Drivers
Table 15. Basal Cell Carcinoma Treatment Market Challenges
Table 16. Basal Cell Carcinoma Treatment Market Restraints
Table 17. Global Basal Cell Carcinoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Basal Cell Carcinoma Treatment Market Share by Players (2016-2021)
Table 19. Global Top Basal Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Cell Carcinoma Treatment as of 2020)
Table 20. Ranking of Global Top Basal Cell Carcinoma Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Basal Cell Carcinoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Basal Cell Carcinoma Treatment Product Solution and Service
Table 24. Date of Enter into Basal Cell Carcinoma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Basal Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Basal Cell Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Basal Cell Carcinoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Basal Cell Carcinoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Basal Cell Carcinoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Basal Cell Carcinoma Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Basal Cell Carcinoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Basal Cell Carcinoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Basal Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Basal Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Basal Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Basal Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Basal Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Basal Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Basal Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Basal Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Basal Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Basal Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Basal Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Basal Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Basal Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Basal Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Basal Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Basal Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Basal Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Basal Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Basal Cell Carcinoma Treatment Product
Table 67. Roche Revenue in Basal Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Sun Pharmaceuticals Company Details
Table 70. Sun Pharmaceuticals Business Overview
Table 71. Sun Pharmaceuticals Basal Cell Carcinoma Treatment Product
Table 72. Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 73. Sun Pharmaceuticals Recent Development
Table 74. Bausch Health Companies Company Details
Table 75. Bausch Health Companies Business Overview
Table 76. Bausch Health Companies Basal Cell Carcinoma Treatment Product
Table 77. Bausch Health Companies Revenue in Basal Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 78. Bausch Health Companies Recent Development
Table 79. Taro Pharmaceuticals Company Details
Table 80. Taro Pharmaceuticals Business Overview
Table 81. Taro Pharmaceuticals Basal Cell Carcinoma Treatment Product
Table 82. Taro Pharmaceuticals Revenue in Basal Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 83. Taro Pharmaceuticals Recent Development
Table 84. Mylan Company Details
Table 85. Mylan Business Overview
Table 86. Mylan Basal Cell Carcinoma Treatment Product
Table 87. Mylan Revenue in Basal Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 88. Mylan Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Basal Cell Carcinoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Topical Treatment Features
Figure 3. Hedgehog Pathway Inhibitor Therapy Features
Figure 4. Mohs Surgery Features
Figure 5. Other Surgeries Features
Figure 6. Other Treatments Features
Figure 7. Global Basal Cell Carcinoma Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Basal Cell Carcinoma Treatment Report Years Considered
Figure 12. Global Basal Cell Carcinoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Basal Cell Carcinoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Basal Cell Carcinoma Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Basal Cell Carcinoma Treatment Market Share by Regions (2022-2027)
Figure 16. Global Basal Cell Carcinoma Treatment Market Share by Players in 2020
Figure 17. Global Top Basal Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Cell Carcinoma Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Basal Cell Carcinoma Treatment Revenue in 2020
Figure 19. Global Basal Cell Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Basal Cell Carcinoma Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Basal Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 23. North America Basal Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 24. North America Basal Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 25. United States Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Basal Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 29. Europe Basal Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 30. Europe Basal Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 31. Germany Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Basal Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Basal Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Basal Cell Carcinoma Treatment Market Share by Region (2016-2027)
Figure 41. China Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Basal Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Basal Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Basal Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Basal Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Basal Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Basal Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Basal Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2016-2021)
Figure 61. Sun Pharmaceuticals Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2016-2021)
Figure 62. Bausch Health Companies Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2016-2021)
Figure 63. Taro Pharmaceuticals Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel Cell Carcinoma, a skin malignancy, is caused by the uncontrolled development of Merkel cells in the skin. MCC was originally first described by Toker in 1972. The malady is to a great extent caused by Merkel Cell Polyomavirus (MCV) on parts of the skin in the head, neck and arms, generally oc…
- 世界のハースル細胞がん治療市場 2021：企業別、地域別、種類・用途別 The Hurthle Cell Carcinoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の頭頸部扁平上皮がん（HNSCC）治療市場規模・現状・予測（2021年-2027年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…